Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Adicet Bio, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 98 | 86 | −12 |
| Shares | 75.1M | 64.0M | −11.2M (−14.9%) |
| Value | $176.6M | $77.4M | −$99.2M (−56.2%) |
New holders (18)
Institutions that held Adicet Bio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,531,194 | $3.06M | 2.95% |
| RBF Capital, LLC | 370,000 | $447.7K | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 191,313 | $231.5K | 0.01% |
| Alpine Global Management, LLC | 118,255 | $143.1K | 0.02% |
| Centiva Capital, LP | 108,600 | $131.4K | 0.01% |
| Verition Fund Management LLC | 80,036 | $96.8K | 0.00% |
| HRT Financial LP | 63,914 | $77.0K | 0.00% |
| Paloma Partners Management Co | 63,018 | $76.3K | 0.01% |
| Point72 Asia (Singapore) Pte. Ltd. | 50,888 | $61.6K | 0.01% |
| Marshall Wace, LLP | 35,323 | $42.7K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 27,659 | $33.5K | 0.00% |
| Bank of Montreal | 12,504 | $18.5K | 0.00% |
| Gsa Capital Partners LLP | 15,005 | $18.0K | 0.00% |
| Ground Swell Capital, LLC | 14,334 | $17.3K | 0.02% |
| Catalyst Funds Management Pty Ltd | 13,700 | $16.6K | 0.00% |
| JustInvest LLC | 11,623 | $14.1K | 0.00% |
| Macquarie Group Ltd | 2,693 | $3.26K | 0.00% |
| Federated Hermes, Inc. | 1,153 | $1.40K | 0.00% |
Sold out (30)
Institutions that held Adicet Bio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.